Crossref
Center-based probiotic supplementation in vonoprazan-amoxicillin dual therapy for first-line Helicobacter pylori eradication
World Journal of Gastroenterology · 17.11.2026
DOI: 10.3748/wjg.126600 ↗Kurz gefasst
Fachartikel in der Zeitschrift World Journal of Gastroenterology, online erschienen am 17.11.2026. Verfasst von Ying Li und 4 weiteren Autor:innen.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Li, Y., Zhou, Y., Li, C., Xu, M., & Hu, L. (2026). Center-based probiotic supplementation in vonoprazan-amoxicillin dual therapy for first-line Helicobacter pylori eradication. World Journal of Gastroenterology. https://doi.org/10.3748/wjg.126600
Vancouver
Li Y, Zhou Y, Li C, Xu M, Hu L. Center-based probiotic supplementation in vonoprazan-amoxicillin dual therapy for first-line Helicobacter pylori eradication. World Journal of Gastroenterology. 2026. doi:10.3748/wjg.126600
BibTeX
@article{Li2026,
author = {Li, Ying and Zhou, Yu-Yang and Li, Chang-Ping and Xu, Mei and Hu, Lian},
title = {Center-based probiotic supplementation in vonoprazan-amoxicillin dual therapy for first-line Helicobacter pylori eradication},
journal = {World Journal of Gastroenterology},
year = {2026},
doi = {10.3748/wjg.126600}
}
EUVIMED